High-sensitivity Troponins - Difficult Friends in Acute Coronary Syndromes

Login or register to view PDF.
Citation
European Cardiology - Volume 8 Issue 3;2012:8(3):181-5
DOI
http://dx.doi.org/10.15420/ecr.2012.8.3.181

Abstract

The introduction of novel high-sensitivity cardiac troponin (hs-cTn) assays has made it possible to measure cardiac troponin levels that are up to 10-fold lower than those detectable by conventional cardiac troponin (cTn) assays. With such novel assays, an elevated risk of major adverse cardiovascular events was noted across the continuum of cTn levels, with an incremental risk of increasing levels even in healthy individuals, but also in patients with stable coronary artery disease, congestive heart failure or acute coronary syndrome (ACS). The rapid triage of patients presenting to the accident and emergency department with chest pain is critical to ensure optimal management, and the novel hs-cTn assays provide a valuable tool for a more rapid exclusion of acute myocardial infarction (AMI), with a higher sensitivity, negative predictive value and diagnostic accuracy compared with conventional cTn assays. The associated decrease in specificity and positive predictive value for the diagnosis of AMI can be overcome by serial measurements to assess the absolute and relative increases in cTn levels. This article provides a contemporary overview of the role of hs-cTn in the detection of individuals with subclinical disease, diagnosis of ACS, risk stratification and clinical management. Furthermore, aspects of uncertainty, such as cut-offs, and the role of hs-cTn for clinical decision-making are addressed.

To view the full article in PDF or eBook formats, please click on the icons above.

References
  1. Fox KA, Steg PG, Eagle KA, et al., Decline in rates of death and heart failure in acute coronary syndromes, 1999–2006, JAMA, 2007;297:1892–900.
    Crossref | PubMed
  2. Fox KA, Carruthers KF, Dunbar DR, et al., Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK–Belgian study), Eur Heart J, 2010;31:2755–64.
    Crossref | PubMed
  3. Roger VL, Weston SA, Gerber Y, et al., Trends in incidence, severity, and outcome of hospitalized myocardial infarction, Circulation, 2010;121:863–9.
    Crossref | PubMed
  4. Hamm CW, Bassand JP, Agewall S, et al., ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC), Eur Heart J, 2011;32:2999–3054.
    Crossref | PubMed
  5. O’Connor RE, Brady W, Brooks SC, et al., Part 10: Acute coronary syndromes: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care, Circulation, 2010;122:S787–817.
    Crossref | PubMed
  6. Thygesen K, Alpert JS, White HD, Universal definition of myocardial infarction, Eur Heart J, 2007;28:2525–38.
    Crossref | PubMed
  7. Scirica BM, Acute coronary syndrome: emerging tools for diagnosis and risk assessment, J Am Coll Cardiol, 2010;55:1403–15.
    Crossref | PubMed
  8. Bavry AA, Kumbhani DJ, Rassi AN, et al., Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials, J Am Coll Cardiol, 2006;48:1319–25.
    Crossref | PubMed
  9. Omland T, de Lemos JA, Sabatine MS, et al., A sensitive cardiac troponin T assay in stable coronary artery disease, N Engl J Med, 2009;361:2538–47.
    Crossref | PubMed
  10. deFilippi CR, de Lemos JA, Christenson RH, et al., Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults, JAMA, 2010;304:2494–502.
    Crossref | PubMed
  11. De Lemos JA, Drazner MH, Omland T, et al., Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population, JAMA, 2010;304:2503–12.
    Crossref | PubMed
  12. Saunders JT, Nambi V, de Lemos JA, et al., Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the atherosclerosis risk in communities study, Circulation, 2011;123:1367–76.
    Crossref | PubMed
  13. Sabatine MS, Morrow DA, de Lemos JA, et al., Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35, Eur Heart J, 2009;30:162–9.
    Crossref | PubMed
  14. Kurz K, Giannitsis E, Zehelein J, Katus HA, Highly sensitive cardiac troponin T values remain constant after brief exercise- or pharmacologic-induced reversible myocardial ischemia, Clin Chem, 2008;54:1234–8.
    Crossref | PubMed
  15. Latini R, Masson S, Anand IS, et al., Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure, Circulation, 2007;116:1242–9.
    Crossref | PubMed
  16. Morrow DA, Cannon CP, Jesse RL, et al., National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes, Circulation, 2007;115:e356–75.
    Crossref | PubMed
  17. Keller T, Zeller T, Peetz D, et al., Sensitive troponin I assay in early diagnosis of acute myocardial infarction, N Engl J Med, 2009;361:868–77.
    Crossref | PubMed
  18. Reichlin T, Hochholzer W, Bassetti S, et al., Early diagnosis of myocardial infarction with sensitive cardiac troponin assays, N Engl J Med, 2009;361:858–67.
    Crossref | PubMed
  19. Reiter M, Twerenbold R, Reichlin T, et al., Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays, Eur Heart J, 2011;32:1379–89.
    Crossref | PubMed
  20. Januzzi JL Jr, Bamberg F, Lee H, et al., High-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography, Circulation, 2010;121:1227–34.
    Crossref | PubMed
  21. Giannitsis E, Becker M, Kurz K, et al., High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission, Clin Chem, 2010;56:642–50.
    Crossref | PubMed
  22. Apple FS, Pearce LA, Smith SW, et al., Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events, Clin Chem, 2009;55:930–7.
    Crossref | PubMed
  23. Reichlin T, Irfan A, Twerenbold R, et al., Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction, Circulation, 2011;124:136–45.
    Crossref | PubMed
  24. Giannitsis E, Kehayova T, Vafaie M, Katus HA, Combined testing of high-sensitivity troponin T and copeptin on presentation at prespecified cutoffs improves rapid rule-out of non-ST-segment elevation myocardial infarction, Clin Chem, 2011;57:1452–5.
    Crossref | PubMed
  25. Karakas M, Januzzi JL Jr, Meyer J, et al., Copeptin does not add diagnostic information to high-sensitivity troponin T in low- to intermediate-risk patients with acute chest pain: results from the Rule Out Myocardial Infarction by Computed Tomography (ROMICAT) study, Clin Chem, 2011;57:1137–45.
    Crossref | PubMed
  26. Keller T, Tzikas S, Zeller T, et al., Copeptin improves early diagnosis of acute myocardial infarction, J Am Coll Cardiol, 2010;55:2096–106.
    Crossref | PubMed
  27. Celik S, Giannitsis E, Wollert KC, et al., Cardiac troponin T concentrations above the 99th percentile value as measured by a new high-sensitivity assay predict long-term prognosis in patients with acute coronary syndromes undergoing routine early invasive strategy, Clin Res Cardiol, 2011;100:1077–85.
    Crossref | PubMed
  28. Lindahl B, Venge P, James S, The new high-sensitivity cardiac troponin T assay improves risk assessment in acute coronary syndromes, Am Heart J, 2010;160:224–9.
    Crossref | PubMed
  29. Kavsak PA, Wang X, Ko DT, et al., Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (HS-CTNI) assay in an emergency department chest pain population, Clin Chem, 2009;55:1809–15.
    Crossref | PubMed
  30. Antman EM, Cohen M, Bernink PJ, et al., The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making, JAMA, 2000;284:835–42.
    Crossref | PubMed
  31. Morrow DA, Antman EM, Charlesworth A, et al., TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous NPA for treatment of infarcting myocardium early II trial substudy, Circulation, 2000;102:2031–7.
    Crossref | PubMed
  32. Eagle KA, Lim MJ, Dabbous OH, et al., A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry, JAMA, 2004;291:2727–33.
    Crossref | PubMed
  33. Meune C, Drexler B, Haaf P, et al., The GRACE score’s performance in predicting in-hospital and 1-year outcome in the era of high-sensitivity cardiac troponin assays and B-type natriuretic peptide, Heart, 2011;97:1479–83.
    Crossref | PubMed
  34. Hochholzer W, Reichlin T, Twerenbold R, et al., Incremental value of high-sensitivity cardiac troponin T for risk prediction in patients with suspected acute myocardial infarction, Clin Chem, 2011;57:1318–26.
    Crossref | PubMed
  35. Scirica BM, Sabatine MS, Jarolim P, et al., Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial, Eur Heart J, 2011;32:697–705.
    Crossref | PubMed
  36. Ndrepepa G, Braun S, Schulz S, et al., Comparison of prognostic value of high-sensitivity and conventional troponin T in patients with non-ST-segment elevation acute coronary syndromes, Clin Chim Acta, 2011;412:1350–6.
    Crossref | PubMed
  37. Mills NL, Churchhouse AM, Lee KK, et al., Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome, JAMA, 2011;305:1210–6.
    Crossref | PubMed
  38. Morrow DA, Cannon CP, Rifai N, et al., Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial, JAMA, 2001;286:2405–12.
    Crossref | PubMed